CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Stopped early
Conditions studied: Crohn's Disease
In brief
The primary objective of the study is to determine the incidence and pattern of serious and/or clinically significant infections, malignancies, and other serious adverse event (SAE) in participants with Crohn's Disease (CD) treated with natalizumab. The secondary objective of this study in this study population is to evaluate disease severity over time in participants with CD treated with natalizumab based on changes in the Harvey-Bradshaw Index (HBI).
Key facts
- Study ID
- NCT00707512
- Run by
- Biogen
- People needed
- 87
- Starts
- 2008-06-30
- Expected to finish
- 2015-05-28
- Last updated by the study team
- 2024-06-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research site — Scottsdale, Arizona, United States
- Research site — Oceanside, California, United States
- Research site — San Francisco, California, United States
- Research site — Hamden, Connecticut, United States
- Research site — Hartford, Connecticut, United States
- Research site — Gainesville, Florida, United States
- Research site — Miami, Florida, United States
- Research site — Winter Park, Florida, United States
- Research site — Atlanta, Georgia, United States
- Research site — Crestview Hills, Kentucky, United States
- Research site — Lexington, Kentucky, United States
- Research site — Louisville, Kentucky, United States
- Research site — Baltimore, Maryland, United States
- Research site — Boston, Massachusetts, United States
- Research site — Boston, Massachusetts, United States
- Research site — Ann Arbor, Michigan, United States
- Research site — Plymouth, Minnesota, United States
- Research site — Columbia, Missouri, United States
- Research site — Lebanon, New Hampshire, United States
- Research site — Egg Harbor, New Jersey, United States
- Research site — Great Neck, New York, United States
- Research site — Lake Success, New York, United States
- Research site — New York, New York, United States
- Research site — Rochester, New York, United States
- Research site — Troy, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.